FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileTsuruha Holdings Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TSUSF
Tsuruha Holdings Inc. Stock AnalysisComprehensive stock analysis for Tsuruha Holdings Inc. (TSUSF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTSUSF
TSUSF
Tsuruha Holdings Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
TSUSF
Home🔹Stocks🔹Tsuruha Holdings Inc.

Tsuruha Holdings Inc.

🇺🇸TSUSF•OTC

Tsuruha Holdings Inc.

🇺🇸TSUSF•OTC
Market cap
$4.20B
Sentiment

Your view on TSUSF

Mkt Cap
$4.20B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Tsuruha Holdings Inc.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Jun Tsuruha
Headquarters
20-1-21, Kita 24 Johigashi, Sapporo, JP
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Jun Tsuruha
Headquarters
20-1-21, Kita 24 Johigashi, Sapporo, JP
Description

Tsuruha Holdings Inc. operates drugstores in Japan. It sells pharmaceutical and cosmetic products. As of October 15, 2021, the company operated 2,448 stores in Japan and 22 stores in Thailand. The company was founded in 1929 and is headquartered in Sapporo, Japan.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

Fair value for Tsuruha Holdings Inc. from FRC's valuation model, read against the market price. TSUSF last traded at $17.25, 19.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Tsuruha Holdings Inc.. Starting points for Tsuruha Holdings Inc.: P/E 19.2, EPS $115.93, beta 0.15 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Tsuruha Holdings Inc.. Tsuruha Holdings Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Tsuruha Holdings Inc.. Trailing twelve-month EPS for Tsuruha Holdings Inc. stands at $115.93. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

As of Nov 12, 2026 · JPY

Analyst Ratings

Holdconsensus of 1 analyst
  • Strong Buy0
  • Buy0
  • Hold1
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrNov 2026Next QtrFeb 2027Current YearFY Feb 2027Next YearFY Feb 2028
Avg. estimateJPY 19.01JPY 23.71JPY 107.01JPY 129.36
Low estimateJPY 18.68JPY 23.29JPY 105.33JPY 127.33
High estimateJPY 19.39JPY 24.17JPY 108.04JPY 130.61
No. of analysts1111
Year-ago EPSJPY 27.00JPY 34.44JPY 144.03—
Growth-29.6%-31.2%-25.7%—

Revenue Estimate

RevenueCurrent QtrNov 2026Next QtrFeb 2027Current YearFY Feb 2027Next YearFY Feb 2028
Avg. estimateJPY 628.14BJPY 642.35BJPY 2.55TJPY 2.63T
Low estimateJPY 622.00BJPY 631.15BJPY 2.53TJPY 2.59T
High estimateJPY 633.98BJPY 655.60BJPY 2.57TJPY 2.65T
No. of analysts6699
Year-ago revenueJPY 275.06BJPY 618.97BJPY 1.45T—
Growth+128.4%+3.8%+75.6%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Tsuruha Holdings Inc.. Tsuruha Holdings Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Tsuruha Holdings Inc. valued side by side against its closest peers. Tsuruha Holdings Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

News

Latest headlines and market coverage.

Latest headlines and company announcements for Tsuruha Holdings Inc.. Coverage tracks Tsuruha Holdings Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Tsuruha Holdings Inc.

More Medical - Pharmaceuticals companies

  • MDVLQMedAvail Holdings, Inc.
  • MEDXFMedexus Pharmaceuticals Inc.
  • MNZOManzo Pharmaceuticals, Inc.
  • MOOD.CNDoseology Sciences Inc.
  • MSMKFMatsukiyoCocokara & Co.
  • MYCOFNoveris Health Sciences Inc.
  • MYX.AXMayne Pharma Group Limited
  • ACBMAcro Biomedical Co., Ltd.
  • ADIAAdia Nutrition, Inc.
  • ADVTAdvantis Corp.
  • AEGYAlternative Energy Partners, Inc.
  • AIBTAibotics Inc.
TSUSF Analysis
Fair
Past5
Growth1
Health5
Profit1
Value2

News

Latest Market News